Abstract
BACKGROUND
Unannounced pill counts conducted in patients’ homes is a valid objective method for monitoring medication adherence that is unfortunately costly and often impractical. Conducting unannounced pill counts by telephone may be a viable alternative for objectively assessing medication adherence.
PURPOSE
To test an unannounced pill count assessment of adherence conducted by telephone.
METHODS
HIV-positive men and women (N = 77) in Atlanta GA completed an unannounced telephone-based pill count immediately followed by a pill count conducted in an unannounced home visit.
RESULTS
A high degree of concordance was observed between phone and home-based number of pills counted (Intraclass correlation, ICC = .997, 95% CI .995–.998, P < .001) and percent of pills taken (ICC = .990, 95% CI .986–.992, P < .001). Concordance between adherence above/below 90% and phone/home counts was 95%, Kappa coefficient = .995. Concordance between pill counts was not influenced by participant education or health literacy and was maintained when the data were censored to remove higher levels of adherence. Analyses of discordant pill counts found the most common source of error resulted from overcounted doses in pillboxes on the telephone.
CONCLUSIONS
Unannounced phone-based pill counts offer an economically and logistically feasible objective method for monitoring medication adherence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bangsberg DR, Acosta EP, Gupta R, Guzman D, Riley ED, Harrigan PR, Parkin N, Deeks R. Adherence-resistence relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006;20:223–231.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.
Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A. Provider assessment of adherence to HIV antiretroviral therapy. J AIDS. 2001a;26:435–442.
Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42:649–652.
Simoni J, Kurth AE, Pearson C, Pantalone DW, Merrill J, Frick P. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10:227–331.
Wagner G, Miller LG. Is the influence of social desirability on patient’s self-reported adherence overrated? J AIDS. 2004;36:203–204.
Wendel CS, Mohler JM, Kroesen K, Ampel NM, Gifford AL, Coons SJ. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001;35:1010–1015.
Kalichman DC, Cain D, Cherry C, Kalichman M, Pope H. Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care STDs. 2005;19:49–55.
Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57:1007–1110.
Grymonpre RE, Didur CD, Montgomery PR, Sitar DS. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother. 1998;32:749–754.
Liechty C, Alexander C, Harrigan R, Guzman D, Charlebois E, Moss A, Bangsberg D. Are untimed antiretroviral drug levels useful predictors of adherence behavior? AIDS. 2004;18:121–129.
Rabkin JG, Chesney M. Treatment adherence to HIV medications: the Achilles heel of the new therapeutics. In: Ostrow D, Kalichman S, eds. Behavioral and Mental Health Impacts of New HIV Therapies. New York: Plenum Press; 1999.
Bangsberg DR, Hecht FM, Charlebois ED, Chesney M, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001;5:275–281.
Bangsberg DR, Hecht FM, Charlebois ED, Zopola AR, Holodniy M, Sheiner L, Bamberger JD, Chesney M, Moss A. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–366.
Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg D. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74–79.
Oyugi JH, Byakika-Tuslime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg D. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J AIDS. 2004;36:1100–1102.
Parker RM, Baker DW, Williams MV, Nurss JR. The test of functional health literacy in adults: a new instrument for measuring patients’ literacy skills. J Gen Intern Med. 1995;10:537–541.
Acknowledgements
The authors thank the AIDS Survival Project of Atlanta for their assistance with data collection and Drs. David Bangsberg, David Guzman, Andrew Moss, and the REACH Cohort study team at the University of California San Francisco for generously sharing their original protocol. National Institute of Mental Health (NIMH) Grant R01-MH71164 supported this research.
Conflict of Interest
None disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kalichman, S.C., Amaral, C.M., Stearns, H. et al. Adherence to Antiretroviral Therapy Assessed by Unannounced Pill Counts Conducted by Telephone. J GEN INTERN MED 22, 1003–1006 (2007). https://doi.org/10.1007/s11606-007-0171-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-007-0171-y